Suppr超能文献

肝移植受者的随访。

Follow-up of liver transplant recipients.

机构信息

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.

出版信息

Best Pract Res Clin Gastroenterol. 2020 Jun-Aug;46-47:101682. doi: 10.1016/j.bpg.2020.101682. Epub 2020 Sep 11.

Abstract

The number of surviving liver allograft recipients is increasing almost exponentially. The quality and length of life is increasing but most recipients have reduced survival and quality of life compared with healthy matched individuals. Causes of premature death include cardio and cerebrovascular disease, renal failure, graft failure, de novo malignancy and recurrent disease. Follow-up is needed lifelong to ensure graft and patient health and ensure that complications are recognised and treated early. Immunosuppression is kept to the appropriate minimum and prophylactic interventions are given early, such as use of statins and tight control of blood pressure and blood sugar. Recipients will require life-long follow-up, and this is placing an increasing burden on transplant units. Follow-up is best done by close collaboration between the Liver Transplant Unit, the local hospital and primary care team. Involvement of other health care practitioners, such as recipient coordinators, pharmacists, dermatologists and addiction specialists may improve outcomes. Key to successful follow-up are agreed protocols and good communication between the recipients and all relevant health care providers. Use of IT allows for better communication and will support use of video and telephone consultations in selected instances. The most appropriate follow-up will depend on many factors, including logistic and geographic issues, local experience. The provision of well-funded and supported registries at local, national and international levels will allow for improvements in management.

摘要

肝移植受者的存活率正在呈指数级增长。受者的生活质量和寿命都在提高,但与健康的匹配个体相比,大多数受者的存活率和生活质量都有所下降。导致过早死亡的原因包括心脑血管疾病、肾衰竭、移植物衰竭、新发恶性肿瘤和复发性疾病。需要终身随访,以确保移植物和患者的健康,并确保早期识别和治疗并发症。免疫抑制作用保持在适当的最低水平,并尽早进行预防性干预,如使用他汀类药物以及严格控制血压和血糖。受者需要终身随访,这给移植单位带来了越来越大的负担。随访最好由肝移植单位、当地医院和初级保健团队之间密切合作来完成。其他卫生保健从业者的参与,如受者协调员、药剂师、皮肤科医生和成瘾专家的参与,可能会改善治疗效果。成功随访的关键是受者与所有相关卫生保健提供者之间达成一致的方案和良好的沟通。信息技术的使用可以促进更好的沟通,并支持在特定情况下使用视频和电话咨询。最适当的随访将取决于许多因素,包括后勤和地理问题、当地经验。在地方、国家和国际各级提供资金充足和得到支持的登记处,将有助于改善管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e3/7485448/f065118ec0ae/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验